Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059810 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Investigational Multifocal Contact Lenses
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03059810 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 72 participants.
The verdict
NCT03059810, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
3-visit dispensing study to evaluate the subjective feedback of a multifocal contact lens in a population of presbyopic patients. Subjects will wear the contact lenses for a total of 12-16 days.
Interventions
- DEVICE etafilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2017-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03059810
The ClinicalTrials.gov registry entry for NCT03059810 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which etafilcon A is the first listed.
NCT03059810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03059810 about?
NCT03059810 is a clinical study titled "Clinical Evaluation of Investigational Multifocal Contact Lenses". 3-visit dispensing study to evaluate the subjective feedback of a multifocal contact lens in a population of presbyopic patients. Subjects will wear the contact lenses for a total of 12-16 days.
What is the current status of trial NCT03059810?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2017-01-27. Estimated completion is 2017-04-25.
What interventions are being tested in trial NCT03059810?
The interventions under investigation include: etafilcon A (DEVICE).
Who is sponsoring clinical trial NCT03059810?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.